Eurofins Scient (ERFSF) Stock Price, News & Analysis

Company Overview

Eurofins Scientific SE is an international laboratory testing and research services company headquartered in Luxembourg. The company provides analytical, scientific and diagnostic services to customers in the pharmaceutical, food, environmental, agricultural, consumer products and healthcare sectors.

Its services include testing and quality control for food, water, soil, pharmaceuticals and consumer goods; environmental analysis; genomic and genetic testing; clinical diagnostics; and support for pharmaceutical and biotechnology research, development and manufacturing. Eurofins operates through a network of laboratories and service locations across Europe, North America, South America, Asia-Pacific and other international markets.

Eurofins was founded in 1987 by Gilles Martin and initially focused on food authenticity testing. It has since expanded through organic growth and acquisitions into a broad provider of laboratory and scientific services. Gilles Martin serves as chief executive officer and chairman of the company’s board.

Key Stats

• Today's Range: $84.88 to $88.41
• 50-Day Range: $77.79 to $91.32
• 52-Week Range: $64.95 to $92.97
• Volume: 281 shs
• Average Volume: 1,387 shs
• Market Capitalization: $16.54 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Eurofins Scient Stock Analysis - MarketRank™

Eurofins Scient scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Hold

Consensus Rating

Eurofins Scient has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 1 buy rating, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Eurofins Scient has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Eurofins Scient has a P/B Ratio of 3.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

0.15% of the float of Eurofins Scient has been sold short.

Short Interest Ratio / Days to Cover

Eurofins Scient has a short interest ratio ("days to cover") of 138.12, which indicates bearish sentiment.

Change versus previous month

Short interest in Eurofins Scient has recently increased by 0.57%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Eurofins Scient does not currently pay a dividend.

Dividend Growth

Eurofins Scient does not have a long track record of dividend growth.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.11

News Sentiment

Eurofins Scient has a news sentiment score of 0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Eurofins Scient this week, compared to 2 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Eurofins Scient insiders have not sold or bought any company stock.

Percentage Held by Institutions

Eurofins Scient has minimal institutional ownership at this time.

Company Calendar

• Today: 10/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ERFSF
• Previous Symbol: NASDAQ:ERFSF
• CIK: N/A
• Web: www.eurofins.com
• Phone: (522) 618-5320
• Fax: 352-2618-5331
• Employees: 65,000
• Year Founded: 1987

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.80
• Current Ratio: 1.13
• Quick Ratio: 1.07

Sales & Book Value

• Annual Sales: $8.25 billion
• Price / Sales: 2.00
• Cash Flow: $8.08 per share
• Price / Cash Flow: 10.79
• Book Value: $27.31 per share
• Price / Book: 3.19

Miscellaneous

• Outstanding Shares: 189,620,000
• Free Float: N/A
• Market Cap: $16.54 billion
• Optionable: Not Optionable
• Beta: 0.54